Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2013-04-30 | Joseph J. Krivulka, age 61, has served as our director since March 2005. Mr. Krivulka is the founder and current Chairman of Akrimax Pharmaceuticals, LLC... Four directors comprised the audit committee at the end of the 2012 fiscal year: Ms. Wang, who chairs the committee, and Messrs. Greer, Krivulka, and Winger... Four directors comprised the organization and compensation committee at the end of the 2012 fiscal year: Mr. Lingnau, who chaired the committee, and Messrs. Greer, Krivulka and Kuebler... Director Compensation Table for 2012 shows Joseph J. Krivulka received total compensation of $264,854. |
| 2014-04-30 | Joseph J. Krivulka, age 62, has served as our director since March 2005. Mr. Krivulka is the founder and current Chairman of Akrimax Pharmaceuticals, LLC, an emerging branded pharmaceutical company, and has served in that capacity since its inception in February 2007. He is also the founder and chairman of Rouses Point Pharmaceuticals LLC, a generic pharmaceutical products company, as well as the founder and chairman of MIST Pharmaceuticals, LLC, a cardiovascular pharmaceutical products company. Mr. Krivulka was the founder and President of Triax Pharmaceuticals, a dermatology products company, a position he held from November 2004 through the sale of the company to PreCision Dermatology in April 2012. Mr. Krivulka was a co-founder and President of Reliant Pharmaceuticals, LLC, a company that markets pharmaceutical products, from 1999 until 2004. Mr. Krivulka was formerly Chief Executive Officer of Bertek, Inc., a generic pharmaceutical products company that is a subsidiary of Mylan Inc., and Corporate Vice President of Mylan Inc., a generic pharmaceutical products company. He holds a B.S. from West Virginia Wesleyan College. The Director Plan shows Joseph J. Krivulka received total compensation of $376,055 in 2013. |
| 2015-04-30 | Joseph J. Krivulka, age 63, has served as our director since March 2005. ... Four directors comprised the audit committee at the end of the 2014 fiscal year: Ms. Wang, who chairs the committee, and Messrs. Greer, Krivulka, and Winger. ... The following table shows compensation awarded or paid to our non-employee directors for the fiscal year ended December 31, 2014. Joseph J. Krivulka: $334,963. |
| 2016-04-29 | Joseph J. Krivulka, age 64, has served as our director since March 2005. ... Mr. Krivulka is the founder and current Chairman of Akrimax Pharmaceuticals. ... The audit committee has four directors including Mr. Krivulka. ... The organization and compensation committee has four directors including Mr. Krivulka. ... Director Compensation Table shows Mr. Krivulka received total compensation of $337,636 in 2015. |
Data sourced from SEC filings. Last updated: 2026-02-03